LINC00847通过准miR-455-3p/HDAC4轴来驱动胰腺癌的进展

Shunxin Hao1, Zhi Yao1, Yifeng Liu1

  • 1Department of General Surgery, Wuhan University of Science and Technology Hospital, Wuhan, Hubei, China.

概括

通过调节miR-455-3p/HDAC4轴,LINC00847促进胰腺癌 (PC) 的进展. 针对LINC00847可能为胰腺癌患者提供新的治疗策略.